Cicek M - Search Results

1

2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo.

Cicek M, Iwaniec UT, Goblirsch MJ, Vrabel A, Ruan M, Clohisy DR, Turner RR, Oursler MJ. Cicek M, et al. Cancer Res. 2007 Nov 1;67(21):10106-11. doi: 10.1158/0008-5472.CAN-07-1362. Cancer Res. 2007. PMID: 17974950

2

Breast cancer bone metastasis and current small therapeutics.

Cicek M, Oursler MJ. Cicek M, et al. Cancer Metastasis Rev. 2006 Dec;25(4):635-44. doi: 10.1007/s10555-006-9035-x. Cancer Metastasis Rev. 2006. PMID: 17160709 Review.

3

TGF-β inducible early gene 1 regulates osteoclast differentiation and survival by mediating the NFATc1, AKT, and MEK/ERK signaling pathways.

Cicek M, Vrabel A, Sturchio C, Pederson L, Hawse JR, Subramaniam M, Spelsberg TC, Oursler MJ. Cicek M, et al. PLoS One. 2011 Mar 14;6(3):e17522. doi: 10.1371/journal.pone.0017522. PLoS One. 2011. PMID: 21423731 Free PMC article.

4

The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton.

Gingery A, Subramaniam M, Pitel KS, Reese JM, Cicek M, Lindenmaier LB, Ingle JN, Goetz MP, Turner RT, Iwaniec UT, Spelsberg TC, Hawse JR. Gingery A, et al. Among authors: cicek m. PLoS One. 2014 May 22;9(5):e98219. doi: 10.1371/journal.pone.0098219. eCollection 2014. PLoS One. 2014. PMID: 24853369 Free PMC article.

5

TGFβ inducible early gene-1 plays an important role in mediating estrogen signaling in the skeleton.

Hawse JR, Pitel KS, Cicek M, Philbrick KA, Gingery A, Peters KD, Syed FA, Ingle JN, Suman VJ, Iwaniec UT, Turner RT, Spelsberg TC, Subramaniam M. Hawse JR, et al. Among authors: cicek m. J Bone Miner Res. 2014;29(5):1206-16. doi: 10.1002/jbmr.2142. J Bone Miner Res. 2014. PMID: 24190163 Free PMC article.

6

TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts.

Subramaniam M, Hawse JR, Bruinsma ES, Grygo SB, Cicek M, Oursler MJ, Spelsberg TC. Subramaniam M, et al. Among authors: cicek m. Biochem Biophys Res Commun. 2010 Jan 29;392(1):72-6. doi: 10.1016/j.bbrc.2009.12.171. Epub 2010 Jan 6. Biochem Biophys Res Commun. 2010. PMID: 20059964 Free PMC article.

7

TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts.

Hawse JR, Cicek M, Grygo SB, Bruinsma ES, Rajamannan NM, van Wijnen AJ, Lian JB, Stein GS, Oursler MJ, Subramaniam M, Spelsberg TC. Hawse JR, et al. Among authors: cicek m. PLoS One. 2011 Apr 29;6(4):e19429. doi: 10.1371/journal.pone.0019429. PLoS One. 2011. PMID: 21559363 Free PMC article.

8

Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.

Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G. Cicek M, et al. Cancer Res. 2005 May 1;65(9):3586-95. doi: 10.1158/0008-5472.CAN-04-3139. Cancer Res. 2005. PMID: 15867352

9

Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.

Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G. Sizemore S, et al. Among authors: cicek m. Cancer Res. 2007 Jul 1;67(13):6183-91. doi: 10.1158/0008-5472.CAN-06-3575. Cancer Res. 2007. PMID: 17616675

10

Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients.

Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP, Dawson AE, Budd GT, Sizemore S, Cicek M, Choueiri TK, Tubbs RR, Gaile D, Nowak N, Accavitti-Loper MA, Frost AR, Welch DR, Casey G. Hicks DG, et al. Among authors: cicek m. Clin Cancer Res. 2006 Nov 15;12(22):6702-8. doi: 10.1158/1078-0432.CCR-06-0635. Clin Cancer Res. 2006. PMID: 17121889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page